JP2017503749A5 - - Google Patents

Download PDF

Info

Publication number
JP2017503749A5
JP2017503749A5 JP2016519779A JP2016519779A JP2017503749A5 JP 2017503749 A5 JP2017503749 A5 JP 2017503749A5 JP 2016519779 A JP2016519779 A JP 2016519779A JP 2016519779 A JP2016519779 A JP 2016519779A JP 2017503749 A5 JP2017503749 A5 JP 2017503749A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
cyclic
acyclic
branched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016519779A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017503749A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/058680 external-priority patent/WO2015051030A2/en
Publication of JP2017503749A publication Critical patent/JP2017503749A/ja
Publication of JP2017503749A5 publication Critical patent/JP2017503749A5/ja
Pending legal-status Critical Current

Links

JP2016519779A 2013-10-01 2014-10-01 安定化されたポリペプチドおよびその使用 Pending JP2017503749A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361885384P 2013-10-01 2013-10-01
US61/885,384 2013-10-01
US201461934618P 2014-01-31 2014-01-31
US61/934,618 2014-01-31
PCT/US2014/058680 WO2015051030A2 (en) 2013-10-01 2014-10-01 Stabilized polypeptides and uses thereof

Publications (2)

Publication Number Publication Date
JP2017503749A JP2017503749A (ja) 2017-02-02
JP2017503749A5 true JP2017503749A5 (enExample) 2018-08-30

Family

ID=52779285

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016519779A Pending JP2017503749A (ja) 2013-10-01 2014-10-01 安定化されたポリペプチドおよびその使用

Country Status (6)

Country Link
US (1) US20160244494A1 (enExample)
EP (1) EP3052520A4 (enExample)
JP (1) JP2017503749A (enExample)
CN (1) CN106103472A (enExample)
IL (1) IL244810A0 (enExample)
WO (1) WO2015051030A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7192713B1 (en) 1999-05-18 2007-03-20 President And Fellows Of Harvard College Stabilized compounds having secondary structure motifs
EP2118123B1 (en) 2007-01-31 2015-10-14 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
EP3159352B1 (en) 2007-03-28 2023-08-02 President and Fellows of Harvard College Stitched polypeptides
KR102104762B1 (ko) 2010-08-13 2020-04-24 에일러론 테라퓨틱스 인코포레이티드 펩티도미메틱 거대고리
TW201806968A (zh) 2011-10-18 2018-03-01 艾利倫治療公司 擬肽巨環化合物
NZ627528A (en) 2012-02-15 2016-05-27 Aileron Therapeutics Inc Peptidomimetic macrocycles
CA2864120A1 (en) 2012-02-15 2013-08-22 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
WO2014138429A2 (en) 2013-03-06 2014-09-12 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and use thereof in regulating hif1alpha
CN105764491A (zh) 2013-12-09 2016-07-13 度瑞公司 药物活性剂复合物、聚合物复合物,以及包括其的组合物和方法
KR20170058424A (ko) 2014-09-24 2017-05-26 에일러론 테라퓨틱스 인코포레이티드 펩티드모방 거대고리 및 이의 용도
MX389354B (es) 2014-09-24 2025-03-20 Aileron Therapeutics Inc Macrociclos peptidomimeticos y formulaciones de los mismos.
SG11201707750YA (en) 2015-03-20 2017-10-30 Aileron Therapeutics Inc Peptidomimetic macrocycles and uses thereof
WO2017004548A1 (en) 2015-07-01 2017-01-05 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
CN110114075B (zh) 2016-11-09 2024-01-12 俄亥俄州国家创新基金会 含有二硫化物的细胞穿透肽及其制备和使用方法
WO2018098282A2 (en) 2016-11-22 2018-05-31 Ohio State Innovation Foundation Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof
WO2018098226A1 (en) 2016-11-22 2018-05-31 Ohio State Innovation Foundation Bicyclic peptidyl inhibitor of tumor necrosis factor-alpha
KR20200064075A (ko) 2017-09-07 2020-06-05 포그 파마슈티컬스 인코포레이티드 베타-카테닌 기능을 조절하는 제제 및 이의 방법
US11339192B2 (en) 2017-10-04 2022-05-24 Ohio State Innovation Foundation Bicyclic peptidyl inhibitors
CA3078682A1 (en) 2017-12-15 2019-06-20 Dana-Farber Cancer Institute, Inc. Stabilized peptide-mediated targeted protein degradation
WO2019136209A1 (en) * 2018-01-05 2019-07-11 President And Fellows Of Harvard College Stabilized polypeptides and uses thereof
EP3749678A1 (en) 2018-02-07 2020-12-16 Dana Farber Cancer Institute, Inc. Cell-permeable stapled peptide modules for cellular delivery
EP3790890A4 (en) 2018-05-09 2022-03-02 Ohio State Innovation Foundation CYCLIC PEPTIDES OF CELL PENETRATION WITH ONE OR MORE HYDROPHOBIC RESIDUES
WO2020023502A1 (en) 2018-07-23 2020-01-30 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
CN113039195A (zh) 2018-08-20 2021-06-25 弗格制药有限公司 肽集合、肽试剂及其使用方法
WO2022092295A1 (ja) * 2020-10-30 2022-05-05 Xeno-Interface株式会社 βストランド型架橋ペプチド

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2367475T3 (es) * 1999-10-15 2011-11-03 Avatar Medical, L.L.C. Proteínas estabilizadas.
PT2332968T (pt) * 2003-11-05 2016-08-17 Harvard College Péptidos alfa-helicoidais adequados para a activação ou inibição da morte celular
DK1689863T3 (da) * 2003-11-15 2014-08-25 Polyphor Ltd Template-fikserede beta-hairpinloopmimetika og deres anvendelse i fag-display
WO2005118620A2 (en) * 2004-05-27 2005-12-15 New York University Methods for preparing internally constraied peptides and peptidomimetics
WO2006069001A2 (en) * 2004-12-20 2006-06-29 Baylor College Of Medicine Structural requirements for stat3 binding and recruitment to phosphototyrosine ligands
EP3159352B1 (en) * 2007-03-28 2023-08-02 President and Fellows of Harvard College Stitched polypeptides
WO2010011313A2 (en) * 2008-07-23 2010-01-28 President And Fellows Of Harvard College Ligation of stapled polypeptides
WO2011008260A2 (en) * 2009-07-13 2011-01-20 President And Fellows Of Harvard College Bifunctional stapled polypeptides and uses thereof
WO2011163423A2 (en) * 2010-06-22 2011-12-29 University Of Central Florida Research Foundation, Inc. Methods and compositions for cell permeable stat3 inhibitor

Similar Documents

Publication Publication Date Title
JP2017503749A5 (enExample)
JP2023025022A (ja) ジスルフィド含有細胞膜透過ペプチド並びにその製造方法及び使用方法
ES2654551T3 (es) Anticuerpo contra el CSF-1R
DK2678037T3 (en) Branched linker for protein pharmaceutical conjugates
JP2014506135A5 (enExample)
FI3354729T3 (fi) Anti-garp-vasta-aine
Baumruck et al. Chemical synthesis of membrane proteins: a model study on the influenza virus B proton channel
ES2882634T3 (es) Compuestos peptídicos y conjugados con péptidos para el tratamiento del cáncer mediante quimioterapia mediada por receptores
CN111420045B (zh) 免疫受体调节剂偶联体及其制备方法和应用、制备其的偶联前体以及合成偶联前体的化合物
EP2750681A1 (en) Branched discrette peg constructs
JP7780253B2 (ja) ステープルペプチドの細胞内送達のためのポリペプチド接合体
ITMI20100093A1 (it) Peptidi ciclici che legano il recettore cxcr4 e relativi usi in campo medico e diagnostico
CN104130315A (zh) 一种特异靶向her2蛋白的多肽
Machida et al. N‐Terminal‐Specific Dual Modification of Peptides through Copper‐Catalyzed [3+ 2] Cycloaddition
Li et al. Greener liquid-phase synthesis and the ACE inhibitory structure–activity relationship of an anti-SARS octapeptide
US10258695B2 (en) Protein derivatization to endow cell penetration
Mandal et al. Structure–activity studies of phosphopeptidomimetic prodrugs targeting the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3 (Stat3)
JPWO2015125892A1 (ja) 蛋白質の標識化合物
JP7687711B2 (ja) ネイティブケミカルライゲーションを用いる新規フロー合成方法
CN109553590B (zh) 具有谷胱甘肽巯基转移酶抑制功能的化合物及其制备方法
WO2017190061A1 (en) Synthetic dna binding domain peptides and uses thereof
JP6707783B2 (ja) ペプチド化合物及びペプチド化合物の製造方法
WO2019072231A1 (zh) 核磁共振显像化合物、核磁共振显像剂及应用、以及核磁共振成像方法
WO2017214534A1 (en) Synthesis of the arylomycin macrocyclic core
US9593142B2 (en) Aldehyde capture ligation technology for synthesis of amide bonds